eCARTv5 Clinical Deterioration Suite (“eCART”) vs EvidenceMD

EvidenceMD offers a broader range of deployment options, including web, iOS, Android, and a Chrome Extension, making it accessible across various devices and workflows. AgileMD's eCARTv5, while integrated with EHRs, is primarily cloud-based SaaS, which might limit its flexibility for individual clinicians outside of a hospital system. EvidenceMD also emphasizes its user-friendly chat interface and ability to sync history across devices.

AgileMD's eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) specifically designed for continuous patient risk assessment and prediction of clinical deterioration (death or ICU transfer) in hospitalized adult patients. It has undergone extensive retrospective and prospective validation across nearly 3 million patient encounters from 28 hospitals, demonstrating superior performance compared to other early warning scores. EvidenceMD, while providing valuable evidence-based clinical reasoning and diagnostic support, functions more as a comprehensive decision support platform rather than a direct predictive tool for acute patient deterioration.

EvidenceMD offers a transparent pricing model with a free tier, individual, and 'Max' plans, as well as custom enterprise pricing and an API with per-request billing. This provides flexibility for individual clinicians and smaller practices. AgileMD's eCARTv5 requires contacting the vendor for a tailored quote, indicating a less transparent and likely higher entry cost, typical for enterprise-focused solutions.

AgileMD's eCARTv5 is specifically designed for integration into Electronic Health Record (EHR) systems, analyzing up to 97 real-time variables to provide continuous patient risk assessment. It is FDA-cleared and HIPAA compliant, and its focus on hospital-wide clinical deterioration prediction with embedded clinical pathways demonstrates a strong enterprise-level solution for improving patient outcomes and efficiency within health systems. EvidenceMD also offers enterprise solutions with BAA and API access, but its primary focus appears to cater to a broader range of users from individual clinicians to health systems.

Both tools demonstrate significant innovation in their respective areas. AgileMD's eCARTv5 utilizes a gradient-boosted machine-learning model for highly accurate, all-cause clinical deterioration prediction, a critical and complex challenge in hospital care. EvidenceMD innovates by providing transparent, evidence-based clinical reasoning with a 'chain-of-thought' approach, citing peer-reviewed literature and guidelines, and offering a unique combination of features like an AI medical scribe and presentation maker.

Both companies emphasize robust support and documentation through their product descriptions. AgileMD highlights its peer-reviewed and validated tools with numerous publications and rapid, seamless implementation. EvidenceMD stresses its transparent logic, continuous updates, and citations from trusted scientific sources, implying comprehensive documentation for its evidence-based reasoning. Without direct access to their support portals or documentation, it is difficult to definitively declare a winner.